Point of Care Diagnostics For Maternal Health Market Size (2023 – 2030)

The Point of Care Diagnostics For Maternal Health Market was valued at USD 35.89 million in 2022 and is anticipated to reach a valuation of USD 65.55 million by the end of 2030. Over the forecast period of 2023-2030, the market is projected to grow at a CAGR of 7.82%. 

In the past, diagnostics for maternal health were limited due to the absence of robust healthcare infrastructure and technological advancements. This resulted in high maternal mortality rates, leading to future complications in pregnancy. Additionally, age-old cultural and societal practices limited the use of diagnostics practices and focused more on home remedies for maternal health, which ultimately affected the future functioning of the woman’s body negatively. However, the present scenario witnessed an immense transformation in the maternal healthcare sector, which was deeply augmented by advancements in technology such as genetic testing and monitoring, incorporation of ultrasounds, quick blood and urine test support care devices, and expansion of digital healthcare solutions. This considerably reduced mortality rates and contributed to the development of maternal healthcare. The future holds positive for the point of care diagnostics for the maternal health market. Upward trends in AI, machine learning, big data, and others are anticipated to enhance the market opportunities for maternal health diagnosis. Further, rising healthcare awareness backed by increased government support for health tech is shaping the market for point-of-care diagnostics for maternal health in the market.

Key Market Insights:

As per WHO, 95% of maternal deaths occurred in low and lower-middle-income countries in the year 2020. The birth rate in India was 17.377 births per 1000 people in 2021. As per Cleveland Clinic, at-home pregnancy tests are 99% accurate when you use them correctly. As per UNICEF, approximately 73% of births among rural mothers were done by skilled health personnel. Institutional deliveries in India increased to 89% in 2019-20 compared to previous period levels. A global health survey by BMJ Global Health found that 58% of maternal & and infant health providers used telehealth.

Point of Care Diagnostics For Maternal Health Market Drivers:

Rising risks in maternal health have boosted the demand point of point-of-care diagnostics for maternal health in the market.

Maternal health is exposed to various risks, and the casualties have increased quickly in recent years. As per WHO, every day in the year 2020, 800 women died from preventable causes associated with pregnancy & and childbirth. The risk factors range from environmental impact on the baby and mother or genetic complications, which require in-depth analysis, and the demand for point-of-care diagnostics for maternal health has increased in the market. Furthermore, many pregnant women suffer from chronic diseases such as heart disease, hypertension, acute anxiety issues, obesity, thyroid, diabetes, and others which can have a direct impact on the baby. By incorporating point-of-care diagnostics these risks can be eliminated, as these devices and kits help in monitoring and early detection of abnormalities in pregnancy such as the impact of genetic disease on the baby, potential infections, post-natal issues, chromosomal abnormalities, and other.

Rising demand for convenience diagnosis drives the market growth for point-of-care diagnostics for maternal health.

The growth of convenience diagnostics has increased in recent times due to hectic and busy working schedules, as women increase their participation in the workforce. Moreover, these diagnostics deliver quick, efficient, and accurate results at home, thus reducing casualties and delays in the absence of efficient healthcare infrastructure in various regions. Moreover, it serves as a hassle-free option for women, as they need not take doctor appointments for testing and diagnosing, leading to a considerable reduction in waiting times. Furthermore, the integration of smart technologies to mobile and tablets such as AI support has further shaped the market landscape of point-of-care diagnostics for maternal health. In addition, it offers personalized and customized solutions to women that cater to various testing and monitoring needs in one platform. Furthermore, rising demand for automated and portable technologies such as portable ultrasound devices and pregnancy monitoring devices has further boosted the demand for convenient at-home maternal health care solutions in the market.

Point of Care Diagnostics For Maternal Health Market Restraints and Challenges:

Quality and accuracy issues can hinder the market growth of point-of-care diagnostics for maternal health in the market. Some POCD testing kits may produce inaccurate results, which can affect the treatment process for maternal health.

Furthermore, the complexity of handling at-home care testing kits can reduce consumer demand for point-of-care diagnostics for maternal health in the market.

Point of Care Diagnostics For Maternal Health Market Opportunities:

The Point of Care Diagnostics For Maternal Health Market is anticipated to deliver lucrative opportunities for businesses, which include acquisitions, partnerships, collaborations, product launches, and agreements during the forecasted period. Furthermore, increasing demand for convenience diagnosing technologies and rapid adoption of telehealth in various countries are predicted to develop the market for Point Care Diagnostics For Maternal Health and enhance its future growth opportunities.

POINT OF CARE DIAGNOSTICS FOR MATERNAL HEALTH MARKET REPORT COVERAGE:

Point of Care Diagnostics For Maternal Health Market Segmentation: By Type of Tests

• Pregnancy Tests

• Infectious Disease Testing

• Foetal Health Testing

• Labour Delivery Monitoring

• Others

In 2022, based on market segmentation by type of tests, pregnancy tests occupy the highest share of about 29% in the market. Pregnancy tests hold a major part of point-of-care maternal health testing since the kits available in this segment are extensively used to monitor and confirm pregnancy. These include at-home pregnancy test kits, urine hCG test kits, blood serum test hCG test kits, and others. Moreover, these kits are capable of detecting early stages of pregnancy and help in immediate treatment. Furthermore, this has reduced delays and pregnancy complications and ensured healthcare professionals in providing appropriate treatment.

Fetal health testing is the fastest-growing segment during the forecast period. Fetal health testing is critical in maternal health, as it focuses on the fetus's development status during pregnancy and identifies potential complications. These include the use of ultrasound scanners, fetal heart rate monitoring devices & and kits, non-evasive prenatal testing, and others. By incorporating such tests, women can ensure their fetus's development, analyze complications such as genetic abnormalities, early detection of diseases in the child, and others. Furthermore, fetus health testing has helped in reducing prenatal mortality and increased the efficiency of maternal treatment.

Point of Care Diagnostics For Maternal Health Market Segmentation: By End-User

• Hospitals & Clinics

• At-Home Care

• Diagnostic Laboratories & Centers

• Others

In 2022, based on market segmentation by end-users, hospitals & clinics occupy the highest share of about 34% in the market. Hospitals & clinics are the major consumers of point-of-care testing for maternal health, as they have to cater to a large number of pregnant women. Further, these testing kits and devices help them in analyzing, monitoring, and detecting anomalies of pregnant women and their babies, which helps them in providing appropriate treatment to women.

The at-home care segment is the fastest-growing segment during the forecast period. The growth of this segment is attributed to a shortage of professional health services in certain regions and rising demand for quick and accurate results. Furthermore, pregnancy kits account for a major consumer share in this segment, as these kits help women perform pregnancy tests easily at home and detect early stages of pregnancy. Moreover, it also helps them to monitor their health status such as blood pressure, glucose level, and others during pregnancy.

Point of Care Diagnostics For Maternal Health Market Segmentation: Regional Analysis

• North America

• Europe

• Asia-Pacific

• South America

• Middle East & Africa

In 2022, based on market segmentation by region, North America occupies the highest share of about 26.5% in the market. The growth is attributed to well-established maternal healthcare services and technologically advanced kits for quicker, more efficient, and accurate results, which have contributed to the demand for point-of-care diagnostics for maternal health in the region.

Asia-Pacific is the fastest-growing region during the forecast period. The growth is attributed to the rising number of birth rates in countries such as India and China and rapid adoption of telehealth and medicine, and increased government support for women and children in the form of schemes and programs, which have contributed to the demand for point-of-care diagnostics for maternal health in the region.

COVID-19 Impact Analysis on the Point of Care Diagnostics For Maternal Health Market

The pandemic had a positive impact on the point-of-care diagnostics for the maternal health market. Due to the pandemic, there was a shortage of healthcare services, which led to an increase in demand for at-home testing kits from e-commerce platforms. Moreover, increasing trends in digitization boosted the demand for telehealth and telemedicine, which helped to reduce treatment delays during the pandemic. These include the use of real-time pregnancy, fetus, and maternal health monitoring kits that allow women to send their data directly to the healthcare professional for further analysis and diagnosis. Moreover, real-time testing kits were integrated into mobile applications that enabled healthcare professionals to remotely monitor and analyze maternal health and recommend treatment as per the requirement.

Latest Developments:

The market for point-of-care diagnostics for maternal health market is witnessing an upward trend with the launch of new products and technological innovation. The integration of AI, ML, and big data technologies with testing kits has further transformed the diagnosing procedure and made it easier for healthcare professionals to deploy appropriate treatment procedures. Moreover, the increased online presence of medical & healthcare companies is further anticipated to boost the market for point-of-care diagnostics for maternal health in the market.

• In September 2023, Yourgene Health, launched MagBench, an automated DNA extraction instrument, and kit meant for collecting samples for prenatal testing. The product extracts DNA from maternal plasma and enables clinical laboratories to provide accurate solutions for non-invasive prenatal testing services. The product is available in Asia-Pacific and Middle East markets.
• In June 2023, Salignostics, a UK-based testing kit company launched a saliva-based pregnancy testing kit named – Salistick. The product aims to determine pregnancy by spit test and serves to offer an alternative to urine-based pregnancy tests. The product is available in the UK and Ireland.

Key Players:

1. Maternova

2. DiaSYs

3. EKF Diagnostics

4. AdvinHealthcare

5. AccuQuik Test Kits

6. Ancestry

7. My Heritage

8. Nebula Genomics

9. Sera Prognostics

10. Labcorp Women’s Health